SlideShare ist ein Scribd-Unternehmen logo
1 von 9
Downloaden Sie, um offline zu lesen
IMDRF/SaMD WG/N10FINAL:2013
Final Document
Title: Software as a Medical Device (SaMD): Key Definitions
Authoring Group: IMDRF SaMD Working Group
Date: 9 December 2013
Despina Spanou, IMDRF Chair
This document was produced by the International Medical Device Regulators Forum. There are
no restrictions on the reproduction or use of this document; however, incorporation of this
document, in part or in whole, into another document, or its translation into languages other than
English, does not convey or represent an endorsement of any kind by the International Medical
Device Regulators Forum.
Copyright © 2013 by the International Medical Device Regulators Forum
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
Table of Contents
1.0 Introduction......................................................................................................................4
2.0 Scope ...............................................................................................................................5
3.0 References........................................................................................................................5
4.0 Definitions........................................................................................................................5
5.0 Key Definitions ................................................................................................................6
5.1 Software as a Medical Device .......................................................................................6
5.2 Medical purpose............................................................................................................6
5.2.1 Medical Device......................................................................................................6
5.2.2 In Vitro Diagnostic (IVD) medical device..............................................................7
5.2.3 Additional considerations for SaMD ......................................................................7
5.3 SaMD Changes .............................................................................................................8
5.4 SaMD Manufacturer .....................................................................................................8
5.5 Intended use / intended purpose ....................................................................................9
5.5.1 Additional considerations for SaMD ......................................................................9
9 December 2013 Page 2 of 9
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
Preface
The document herein was produced by the International Medical Device Regulators Forum
(IMDRF), a voluntary group of medical device regulators from around the world. The document
has been subject to consultation throughout its development.
There are no restrictions on the reproduction, distribution or use of this document; however,
incorporation of this document, in part or in whole, into any other document, or its translation
into languages other than English, does not convey or represent an endorsement of any kind by
the International Medical Device Regulators Forum.
9 December 2013 Page 3 of 9
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
1.0 Introduction
Software is becoming increasingly important and pervasive in healthcare. Given the availability
of a multitude of technology platforms (e.g., personal computers, smart phones, network servers,
etc.), as well as increasing ease of access and distribution (e.g., internet, cloud), software created
for medical purposes (software used to make clinical decisions) and non-medical purpose (e.g.,
administrative, financial) are being used in healthcare.
In general, existing regulations address public health risks of software when embedded in a
traditional medical device. However, the current application of regulations and controls may not
always translate or address the unique public health risks posed by Software as a Medical Device
(SaMD) nor assure an appropriate balance between patient/consumer protection and promotion
of public health by facilitating innovation.
This is the first of a collection of documents that will be developed by the International Medical
Device Regulators Forum (IMDRF) to establish a common framework for regulators to
incorporate converged controls into their regulatory approaches for SaMD..
This collection of IMDRF SaMD documents will provide regulators with the fundamental
building blocks and a common understanding of the many kinds and importance of software for
medical purposes in advancing public health. Generally medical purpose software1
consists of:
(1) software in a medical device (sometimes referred to as “embedded” or “part of”);
(2) software as a medical device (SaMD).
This document IMDRF SaMD WG N10/Software as a Medical Device2
: Key Definitions focuses
on a common definition for when software is considered to be a medical device and a reminder
of other key terms, some previously defined in Global Harmonization Task Force (GHTF)
documents, with relevance to SaMD. The key definitions and terms developed in IMDRF SaMD
WG N10 will be used to develop future documents that provide a common framework for
identifying types of SaMD and associated risks and controls to minimize these risks.
Some regulators have taken individual approaches to assure safety, effectiveness, and
performance of SaMD. Such approaches have common public health goals. The objective of this
effort is to promote consistent expectations for SaMD and to provide an optimal level of patient
safety while fostering innovation and ensuring patients and providers have continued access to
advances in healthcare technology.
1
Software used to make or maintain a device (testing, source code management, servicing, etc.) is not considered
software with a medical purpose.
2
This IMDRF document converges on the term SaMD to replace the term “standalone software” or “standalone
medical device software”. However the concepts of standalone software are included in this converged definition
of SaMD.
9 December 2013 Page 4 of 9
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
2.0 Scope
This document IMDRF SaMD WG N10/Software as a Medical Device: Key Definitions focuses
on a common definition for when software is considered to be a medical device and a reminder
of other key terms, some previously defined in Global Harmonization Task Force (GHTF)
documents, with relevance to SaMD.
Software intended as an accessory to a medical device is not in the scope of this document,
unless the software meets the definition of SaMD in this document.
This document focuses on the definition of the SaMD irrespective of software technology and/or
platform (e.g., mobile app, cloud).
3.0 References
• GHTF/SG1/N55:2008 Definition of the Terms Manufacturer, Authorised Representative,
Distributor and Importer
• GHTF/SG1/N70:2011 Label and Instructions for Use for Medical Devices
• GHTF/SG1/N71:2012 Definition of Terms Medical Device and In Vitro Diagnostic
Medical Device
• ISO/IEC 14764:2006 Software Engineering — Software Life Cycle Processes —
Maintenance
4.0 Definitions
This section is intentionally left blank as the definitions are contained within the body of this
document.
9 December 2013 Page 5 of 9
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
5.0 Key Definitions
5.1 Software as a Medical Device
The term “Software as a Medical Device” (SaMD) is defined as software intended to be used for
one or more medical purposes that perform these purposes without being part of a hardware
medical device.
NOTES:
• SaMD is a medical device and includes in-vitro diagnostic (IVD) medical device.
• SaMD is capable of running on general purpose (non-medical purpose) computing platforms3
• “without being part of” means software not necessary for a hardware medical device to
achieve its intended medical purpose;
• Software does not meet the definition of SaMD if its intended purpose is to drive a hardware medical
device.
• SaMD may be used in combination (e.g., as a module) with other products including medical
devices;
• SaMD may be interfaced with other medical devices, including hardware medical devices and
other SaMD software, as well as general purpose software
• Mobile apps that meet the definition above are considered SaMD.
5.2 Medical purpose
The following two terms as defined in GHTF/SG1/N71:2012 (italicized below) identify medical
purpose applicable to SaMD:
5.2.1 Medical Device
‘Medical device’ means any instrument, apparatus, implement, machine, appliance,
implant, reagent for in vitro use, software, material or other similar or related article, intended
by the manufacturer to be used, alone or in combination, for human beings, for one or more of
the specific medical purpose(s) of:
• diagnosis, prevention, monitoring, treatment or alleviation of disease,
• diagnosis, monitoring, treatment, alleviation of or compensation for an injury,
• investigation, replacement, modification, or support of the anatomy or of a
physiological process,
• supporting or sustaining life,
• control of conception,
3
“Computing platforms” include hardware and software resources (e.g. operating system, processing hardware,
storage, software libraries, displays, input devices, programming languages etc.).
“Operating systems” that SaMD require may be run on a server, a workstation, a mobile platform, or other general
purpose hardware platform.
9 December 2013 Page 6 of 9
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
• disinfection of medical devices,
• providing information by means of in vitro examination of specimens derived from
the human body;
and does not achieve its primary intended action by pharmacological, immunological or metabolic
means, in or on the human body, but which may be assisted in its intended function by such means.
Note: Products which may be considered to be medical devices in some jurisdictions but
not in others include:
• disinfection substances,
• aids for persons with disabilities,
• devices incorporating animal and/or human tissues,
• devices for.in-vitro fertilization or assisted reproduction technologies.
5.2.2 In Vitro Diagnostic (IVD) medical device
‘In Vitro Diagnostic (IVD) medical device’ means a medical device, whether used alone
or in combination, intended by the manufacturer for the in-vitro examination of specimens
derived from the human body solely or principally to provide information for diagnostic,
monitoring or compatibility purposes.
Note 1: IVD medical devices include reagents, calibrators, control materials, specimen
receptacles, software, and related instruments or apparatus or other articles and are used,
for example, for the following test purposes: diagnosis, aid to diagnosis, screening,
monitoring, predisposition, prognosis, prediction, determination of physiological status.
Note2: In some jurisdictions, certain IVD medical devices may be covered by other
regulations.
5.2.3 Additional considerations for SaMD
SaMD may also:
• provide means and suggestions for mitigation of a disease;
• provide information for determining compatibility, detecting, diagnosing, monitoring
or treating physiological conditions, states of health, illnesses or congenital
deformities;
• be an aid to diagnosis, screening, monitoring, determination of predisposition;
prognosis, prediction, determination of physiological status.
9 December 2013 Page 7 of 9
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
5.3 SaMD Changes
SaMD Changes refer to any modifications made throughout the lifecycle of the SaMD including
the maintenance phase.
Software maintenance4
can include adaptive (e.g. keeps pace with the changing environment),
perfective (e.g. recoding to improve software performance), corrective (e.g. corrects discovered
problems), or preventive (e.g. corrects latent faults in the software product before they become
operational faults).
Examples of SaMD changes include, but are not limited to, defect fixes; aesthetic, performance
or usability enhancements; and security patches.
5.4 SaMD Manufacturer
For SaMD manufacturer the definition in GHTF/SG1/N55:2009 applies:
“Manufacturer” means any natural or legal person5
with responsibility for design and/or
manufacture of a medical device with the intention of making the medical device available for
use, under his name; whether or not such a medical device is designed and/or manufactured by
that person himself or on his behalf by another person(s).
NOTES:
1. This ‘natural or legal person’ has ultimate legal responsibility for ensuring
compliance with all applicable regulatory requirements for the medical device in the
countries or jurisdictions where it is intended to be made available or sold, unless
this responsibility is specifically imposed on another person by the Regulatory
Authority (RA) within that jurisdiction.
2. The manufacturer’s responsibilities are described in other GHTF guidance
documents. These responsibilities include meeting both pre-market requirements
4
ISO/IEC 14764:2006 Software Engineering — Software Life Cycle Processes — Maintenance
• adaptive maintenance: the modification of a software product, performed after delivery, to keep a
software product usable in a changed or changing environment.
• perfective maintenance: the modification of a software product after delivery to detect and correct latent
faults in the software product before they are manifested as failures
• corrective maintenance: the reactive modification of a software product performed after delivery to
correct discovered problems
• preventive maintenance: the modification of a software product after delivery to detect and correct
latent faults in the software product before they become operational faults
5
The term “person” that appears here and in the other definitions of this document, includes legal entities such as a
corporation, a partnership or an association.
9 December 2013 Page 8 of 9
IMDRF/SaMD WG/N10FINAL:2013
_______________________________________________________________________________________
and post-market requirements, such as adverse event reporting and notification of
corrective actions.
3. ‘Design and/or manufacture’, as referred to in the above definition, may include
specification development, production, fabrication, assembly, processing, packaging,
repackaging, labelling, relabelling, sterilization, installation, or remanufacturing of
a medical device; or putting a collection of devices, and possibly other products,
together for a medical purpose.
4. Any person who assembles or adapts a medical device that has already been
supplied by another person for an individual patient, in accordance with the
instructions for use, is not the manufacturer, provided the assembly or adaptation
does not change the intended use of the medical device.
5. Any person who changes the intended use of, or modifies, a medical device without
acting on behalf of the original manufacturer and who makes it available for use
under his own name, should be considered the manufacturer of the modified medical
device.
6. An authorised representative, distributor or importer who only adds its own address
and contact details to the medical device or the packaging, without covering or
changing the existing labelling, is not considered a manufacturer.
7. To the extent that an accessory is subject to the regulatory requirements of a medical
device6
, the person responsible for the design and/or manufacture of that accessory
is considered to be a manufacturer.
5.5 Intended use / intended purpose
For SaMD intended use, the definition in GHTF/SG1/N70:2011 “Label and Instructions for Use
for Medical Devices” applies:
The term “intended use / intended purpose” is the objective intent of the manufacturer regarding
the use of a product, process or service as reflected in the specifications, instructions and
information provided by the manufacturer.
5.5.1 Additional considerations for SaMD
Although not specifically included in the GHTF definition materials such as sales and
marketing materials may be considered as “information provided by the manufacturer”
and therefore reflect the objective intent of the manufacturer. Sales and marketing
materials should be comprehensive and reflect the intended use of the SaMD.
6
See GHTF/SG1/N29 Information Document Concerning the Definition of the Term “Medical Device”
9 December 2013 Page 9 of 9

Weitere ähnliche Inhalte

Was ist angesagt?

Regulation of medical device in japan
Regulation of medical device in japanRegulation of medical device in japan
Regulation of medical device in japanKrushnaAgnihotri
 
REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxAartiVats5
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Aakashdeep Raval
 
International Medical Device Regulators Forum
International Medical Device Regulators ForumInternational Medical Device Regulators Forum
International Medical Device Regulators ForumSanthiNori1
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingPaulyne Wairimu
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best PracticesCFTCC
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxPrachiSharma575050
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)TGA Australia
 
validation and verification of medical device.pptx
validation and verification of medical device.pptxvalidation and verification of medical device.pptx
validation and verification of medical device.pptxGargiVaghela
 
20210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr202120210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr2021Annet Visscher
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigationsArete-Zoe, LLC
 
ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxAartiVats5
 
Plasma master file
Plasma master filePlasma master file
Plasma master fileSridhar S
 
510kvs pma slides
510kvs pma slides510kvs pma slides
510kvs pma slidesTahir Rizvi
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxFaizanShaikh204666
 
Europe CE Marking for medical devices under new MDR
Europe CE Marking for medical devices under new MDREurope CE Marking for medical devices under new MDR
Europe CE Marking for medical devices under new MDREMERGO
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationShoba Elangovan
 

Was ist angesagt? (20)

CLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICESCLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICES
 
Regulation of medical device in japan
Regulation of medical device in japanRegulation of medical device in japan
Regulation of medical device in japan
 
REGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptxREGULATORY CONSIDERATIONS IN JAPAN.pptx
REGULATORY CONSIDERATIONS IN JAPAN.pptx
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
 
International Medical Device Regulators Forum
International Medical Device Regulators ForumInternational Medical Device Regulators Forum
International Medical Device Regulators Forum
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and grouping
 
China: Medical Device Regulations
China: Medical Device RegulationsChina: Medical Device Regulations
China: Medical Device Regulations
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best Practices
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)
 
Advamed MDR IVDR update
Advamed MDR IVDR updateAdvamed MDR IVDR update
Advamed MDR IVDR update
 
validation and verification of medical device.pptx
validation and verification of medical device.pptxvalidation and verification of medical device.pptx
validation and verification of medical device.pptx
 
20210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr202120210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr2021
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
 
ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptx
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
 
510kvs pma slides
510kvs pma slides510kvs pma slides
510kvs pma slides
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
 
Europe CE Marking for medical devices under new MDR
Europe CE Marking for medical devices under new MDREurope CE Marking for medical devices under new MDR
Europe CE Marking for medical devices under new MDR
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
 

Andere mochten auch

3rd Workshop on Social Information Retrieval for Technology-Enhanced Learnin...
3rd Workshop onSocial  Information Retrieval for Technology-Enhanced Learnin...3rd Workshop onSocial  Information Retrieval for Technology-Enhanced Learnin...
3rd Workshop on Social Information Retrieval for Technology-Enhanced Learnin...Hendrik Drachsler
 
A Long Walk to Water - Lssn 9
A Long Walk to Water - Lssn 9A Long Walk to Water - Lssn 9
A Long Walk to Water - Lssn 9Terri Weiss
 
A Long Walk to Water - Lssn 6
A Long Walk to Water - Lssn 6A Long Walk to Water - Lssn 6
A Long Walk to Water - Lssn 6Terri Weiss
 
DUALL Presentation. Energy, efficiencies and emissions.
DUALL Presentation. Energy, efficiencies and emissions. DUALL Presentation. Energy, efficiencies and emissions.
DUALL Presentation. Energy, efficiencies and emissions. Joss Winn
 
What stakeholders really think of eLearning. Quality through self-evaluation.
What stakeholders really think of eLearning. Quality through self-evaluation.What stakeholders really think of eLearning. Quality through self-evaluation.
What stakeholders really think of eLearning. Quality through self-evaluation.DeborahJane
 
2010 I Rendementbijeenkomst
2010 I Rendementbijeenkomst2010 I Rendementbijeenkomst
2010 I Rendementbijeenkomstmr38schev
 
Team Up with Families: Using Technology to Build Bridges
Team Up with Families: Using Technology to Build BridgesTeam Up with Families: Using Technology to Build Bridges
Team Up with Families: Using Technology to Build BridgesJennifer Orr
 
Mis 2 Princesas Chico 2
Mis 2 Princesas Chico 2Mis 2 Princesas Chico 2
Mis 2 Princesas Chico 2Carlos Arrieta
 
Support & Help for Academic Researchers by using Information Technology (SHA...
Support & Help for Academic Researchers by using Information  Technology (SHA...Support & Help for Academic Researchers by using Information  Technology (SHA...
Support & Help for Academic Researchers by using Information Technology (SHA...Martin Rehm
 
Finding and sharing resources
Finding and sharing resourcesFinding and sharing resources
Finding and sharing resourcesLis Parcell
 
Lift'11 Venture Night Presentation
Lift'11 Venture Night PresentationLift'11 Venture Night Presentation
Lift'11 Venture Night PresentationSebastien Dubuis
 
Lisp batton - Common LISP
Lisp batton - Common LISPLisp batton - Common LISP
Lisp batton - Common LISPMasaomi CHIBA
 
Improve your Presentation Power
Improve your Presentation PowerImprove your Presentation Power
Improve your Presentation PowerAndrea Tanzi
 
Litigation Holds: A primer
Litigation Holds: A primerLitigation Holds: A primer
Litigation Holds: A primerDebbie Westwood
 
Presenting malta etwinning project (dorianne agius)
Presenting malta    etwinning project (dorianne agius)Presenting malta    etwinning project (dorianne agius)
Presenting malta etwinning project (dorianne agius)Gavranica
 
Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.
Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.
Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.Carlo Colomba
 

Andere mochten auch (20)

3rd Workshop on Social Information Retrieval for Technology-Enhanced Learnin...
3rd Workshop onSocial  Information Retrieval for Technology-Enhanced Learnin...3rd Workshop onSocial  Information Retrieval for Technology-Enhanced Learnin...
3rd Workshop on Social Information Retrieval for Technology-Enhanced Learnin...
 
Friends Calendar 2010
Friends Calendar 2010Friends Calendar 2010
Friends Calendar 2010
 
A Long Walk to Water - Lssn 9
A Long Walk to Water - Lssn 9A Long Walk to Water - Lssn 9
A Long Walk to Water - Lssn 9
 
A Long Walk to Water - Lssn 6
A Long Walk to Water - Lssn 6A Long Walk to Water - Lssn 6
A Long Walk to Water - Lssn 6
 
DUALL Presentation. Energy, efficiencies and emissions.
DUALL Presentation. Energy, efficiencies and emissions. DUALL Presentation. Energy, efficiencies and emissions.
DUALL Presentation. Energy, efficiencies and emissions.
 
What stakeholders really think of eLearning. Quality through self-evaluation.
What stakeholders really think of eLearning. Quality through self-evaluation.What stakeholders really think of eLearning. Quality through self-evaluation.
What stakeholders really think of eLearning. Quality through self-evaluation.
 
2010 I Rendementbijeenkomst
2010 I Rendementbijeenkomst2010 I Rendementbijeenkomst
2010 I Rendementbijeenkomst
 
Team Up with Families: Using Technology to Build Bridges
Team Up with Families: Using Technology to Build BridgesTeam Up with Families: Using Technology to Build Bridges
Team Up with Families: Using Technology to Build Bridges
 
Mis 2 Princesas Chico 2
Mis 2 Princesas Chico 2Mis 2 Princesas Chico 2
Mis 2 Princesas Chico 2
 
Web 2.0, comunicazione e marketing
Web 2.0, comunicazione e marketingWeb 2.0, comunicazione e marketing
Web 2.0, comunicazione e marketing
 
Support & Help for Academic Researchers by using Information Technology (SHA...
Support & Help for Academic Researchers by using Information  Technology (SHA...Support & Help for Academic Researchers by using Information  Technology (SHA...
Support & Help for Academic Researchers by using Information Technology (SHA...
 
Finding and sharing resources
Finding and sharing resourcesFinding and sharing resources
Finding and sharing resources
 
Lift'11 Venture Night Presentation
Lift'11 Venture Night PresentationLift'11 Venture Night Presentation
Lift'11 Venture Night Presentation
 
Lisp batton - Common LISP
Lisp batton - Common LISPLisp batton - Common LISP
Lisp batton - Common LISP
 
Improve your Presentation Power
Improve your Presentation PowerImprove your Presentation Power
Improve your Presentation Power
 
Litigation Holds: A primer
Litigation Holds: A primerLitigation Holds: A primer
Litigation Holds: A primer
 
Presenting malta etwinning project (dorianne agius)
Presenting malta    etwinning project (dorianne agius)Presenting malta    etwinning project (dorianne agius)
Presenting malta etwinning project (dorianne agius)
 
Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.
Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.
Occupabilità e competitività come muoversi da protagonista nel mondo che cambia.
 
Palimpsest Maps
Palimpsest MapsPalimpsest Maps
Palimpsest Maps
 
Suisse
SuisseSuisse
Suisse
 

Ähnlich wie Imdrf tech-131209-samd-key-definitions-140901

EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...DayOne
 
The regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devicesThe regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devicesTGA Australia
 
mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017Levi Shapiro
 
Review Mdcg 2019-11 guidance on qualification and classification of software
Review Mdcg 2019-11 guidance on qualification and classification of software Review Mdcg 2019-11 guidance on qualification and classification of software
Review Mdcg 2019-11 guidance on qualification and classification of software Antonio Bartolozzi
 
Challenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciencesChallenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciencesPEPGRA Healthcare
 
EU Medical Device Directive Newcastle May
EU Medical Device Directive Newcastle MayEU Medical Device Directive Newcastle May
EU Medical Device Directive Newcastle MayHANDI HEALTH
 
Regulation of software as medical devices
Regulation of software as medical devicesRegulation of software as medical devices
Regulation of software as medical devicesTGA Australia
 
Mdcg 2019 11 guidance on qualification and classification of software mdr-ivdr
Mdcg 2019 11 guidance on qualification and classification of software mdr-ivdrMdcg 2019 11 guidance on qualification and classification of software mdr-ivdr
Mdcg 2019 11 guidance on qualification and classification of software mdr-ivdrAntonio Bartolozzi
 
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...TGA Australia
 
What is SaMD Model, Benefits, and Development Process.pdf
What is SaMD Model, Benefits, and Development Process.pdfWhat is SaMD Model, Benefits, and Development Process.pdf
What is SaMD Model, Benefits, and Development Process.pdfInexture Solutions
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)TGA Australia
 
Fda mobile medical apps 2013
Fda mobile medical apps 2013Fda mobile medical apps 2013
Fda mobile medical apps 2013Alfonso Gadea
 
olumide adeola pidan
olumide adeola pidanolumide adeola pidan
olumide adeola pidanPraveen kumar
 
Design Controls for Medical Device Data Systems
Design Controls for Medical Device Data SystemsDesign Controls for Medical Device Data Systems
Design Controls for Medical Device Data SystemsEMMAIntl
 
Medical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thoughtMedical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thoughtRenato Monteiro
 
Medical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thoughtMedical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thoughtRenato Monteiro
 
The Move to Mobile
The Move to MobileThe Move to Mobile
The Move to MobileDale Cooke
 
mdcg 2019 11 Decision steps for qualification of software as MDSW
mdcg 2019 11 Decision steps for qualification of software as MDSWmdcg 2019 11 Decision steps for qualification of software as MDSW
mdcg 2019 11 Decision steps for qualification of software as MDSWAntonio Bartolozzi
 

Ähnlich wie Imdrf tech-131209-samd-key-definitions-140901 (20)

EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...
 
The regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devicesThe regulation of software: Medicines, biologicals, blood, tissues and devices
The regulation of software: Medicines, biologicals, blood, tissues and devices
 
mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017mHealth Israel_Digital Health_The Regulatory Landscape 2017
mHealth Israel_Digital Health_The Regulatory Landscape 2017
 
Review Mdcg 2019-11 guidance on qualification and classification of software
Review Mdcg 2019-11 guidance on qualification and classification of software Review Mdcg 2019-11 guidance on qualification and classification of software
Review Mdcg 2019-11 guidance on qualification and classification of software
 
Challenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciencesChallenges and-opportunities-in-software-driven-medical-sciences
Challenges and-opportunities-in-software-driven-medical-sciences
 
EU Medical Device Directive Newcastle May
EU Medical Device Directive Newcastle MayEU Medical Device Directive Newcastle May
EU Medical Device Directive Newcastle May
 
Regulation of software as medical devices
Regulation of software as medical devicesRegulation of software as medical devices
Regulation of software as medical devices
 
Mdcg 2019 11 guidance on qualification and classification of software mdr-ivdr
Mdcg 2019 11 guidance on qualification and classification of software mdr-ivdrMdcg 2019 11 guidance on qualification and classification of software mdr-ivdr
Mdcg 2019 11 guidance on qualification and classification of software mdr-ivdr
 
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
 
What is SaMD Model, Benefits, and Development Process.pdf
What is SaMD Model, Benefits, and Development Process.pdfWhat is SaMD Model, Benefits, and Development Process.pdf
What is SaMD Model, Benefits, and Development Process.pdf
 
Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)Update on software as a medical device (SaMD)
Update on software as a medical device (SaMD)
 
Medical software – us regulation
Medical software – us regulationMedical software – us regulation
Medical software – us regulation
 
160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF160428_WP_Medical_UDI_EN.PDF
160428_WP_Medical_UDI_EN.PDF
 
Fda mobile medical apps 2013
Fda mobile medical apps 2013Fda mobile medical apps 2013
Fda mobile medical apps 2013
 
olumide adeola pidan
olumide adeola pidanolumide adeola pidan
olumide adeola pidan
 
Design Controls for Medical Device Data Systems
Design Controls for Medical Device Data SystemsDesign Controls for Medical Device Data Systems
Design Controls for Medical Device Data Systems
 
Medical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thoughtMedical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thought
 
Medical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thoughtMedical technologies and data protection issues - food for thought
Medical technologies and data protection issues - food for thought
 
The Move to Mobile
The Move to MobileThe Move to Mobile
The Move to Mobile
 
mdcg 2019 11 Decision steps for qualification of software as MDSW
mdcg 2019 11 Decision steps for qualification of software as MDSWmdcg 2019 11 Decision steps for qualification of software as MDSW
mdcg 2019 11 Decision steps for qualification of software as MDSW
 

Kürzlich hochgeladen

Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
 
Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxravisutar1
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...mauryashreya478
 
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE  STUDY ON CHRONIC KIDNEY DISEASE.pptxCASE  STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptxdrsriram2001
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...Compliatric Where Compliance Happens
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinJasper Colin
 
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...drphilspharmacy
 
The Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptxThe Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptxBarshaBarsha6
 
Weighing the Risks and Benefits: Angioplasty at Gokuldas Hospitals
Weighing the Risks and Benefits: Angioplasty at Gokuldas HospitalsWeighing the Risks and Benefits: Angioplasty at Gokuldas Hospitals
Weighing the Risks and Benefits: Angioplasty at Gokuldas HospitalsGokuldas Hospital
 
AMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxAMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxDileepRedemption
 
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...Panchmukhi Air& Train Ambulance Services
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalA-dec Australia
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingNursing education
 
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEMLABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEMRommel Luis III Israel
 
Emergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptxEmergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptxdragonaklevel7
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionNeighborhood Trainer
 
Unlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic SystemUnlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic SystemSasikiranMarri
 
20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health SupportSayhey
 

Kürzlich hochgeladen (20)

Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginess
 
Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptx
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...
 
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE  STUDY ON CHRONIC KIDNEY DISEASE.pptxCASE  STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper Colin
 
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
Buy lsd online, buy lsd, lsd for sale, buy 1P lsd, buy liquid LSD, Buy DMT On...
 
The Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptxThe Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptx
 
Weighing the Risks and Benefits: Angioplasty at Gokuldas Hospitals
Weighing the Risks and Benefits: Angioplasty at Gokuldas HospitalsWeighing the Risks and Benefits: Angioplasty at Gokuldas Hospitals
Weighing the Risks and Benefits: Angioplasty at Gokuldas Hospitals
 
AMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxAMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptx
 
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
Speedy patient rehabilitation by Panchmukhi Train Ambulance Services in Patna...
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa Dental
 
Immediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursingImmediate care of newborn, midwifery and obstetrical nursing
Immediate care of newborn, midwifery and obstetrical nursing
 
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEMLABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
 
Emergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptxEmergency ambulance portal-PPT-3g2pqy.pptx
Emergency ambulance portal-PPT-3g2pqy.pptx
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized Nutrition
 
Unlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic SystemUnlocking the Mysteries of the Lymphatic System
Unlocking the Mysteries of the Lymphatic System
 
20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support20 Benefits of Empathetic Listening in Mental Health Support
20 Benefits of Empathetic Listening in Mental Health Support
 

Imdrf tech-131209-samd-key-definitions-140901

  • 1. IMDRF/SaMD WG/N10FINAL:2013 Final Document Title: Software as a Medical Device (SaMD): Key Definitions Authoring Group: IMDRF SaMD Working Group Date: 9 December 2013 Despina Spanou, IMDRF Chair This document was produced by the International Medical Device Regulators Forum. There are no restrictions on the reproduction or use of this document; however, incorporation of this document, in part or in whole, into another document, or its translation into languages other than English, does not convey or represent an endorsement of any kind by the International Medical Device Regulators Forum. Copyright © 2013 by the International Medical Device Regulators Forum
  • 2. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ Table of Contents 1.0 Introduction......................................................................................................................4 2.0 Scope ...............................................................................................................................5 3.0 References........................................................................................................................5 4.0 Definitions........................................................................................................................5 5.0 Key Definitions ................................................................................................................6 5.1 Software as a Medical Device .......................................................................................6 5.2 Medical purpose............................................................................................................6 5.2.1 Medical Device......................................................................................................6 5.2.2 In Vitro Diagnostic (IVD) medical device..............................................................7 5.2.3 Additional considerations for SaMD ......................................................................7 5.3 SaMD Changes .............................................................................................................8 5.4 SaMD Manufacturer .....................................................................................................8 5.5 Intended use / intended purpose ....................................................................................9 5.5.1 Additional considerations for SaMD ......................................................................9 9 December 2013 Page 2 of 9
  • 3. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ Preface The document herein was produced by the International Medical Device Regulators Forum (IMDRF), a voluntary group of medical device regulators from around the world. The document has been subject to consultation throughout its development. There are no restrictions on the reproduction, distribution or use of this document; however, incorporation of this document, in part or in whole, into any other document, or its translation into languages other than English, does not convey or represent an endorsement of any kind by the International Medical Device Regulators Forum. 9 December 2013 Page 3 of 9
  • 4. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ 1.0 Introduction Software is becoming increasingly important and pervasive in healthcare. Given the availability of a multitude of technology platforms (e.g., personal computers, smart phones, network servers, etc.), as well as increasing ease of access and distribution (e.g., internet, cloud), software created for medical purposes (software used to make clinical decisions) and non-medical purpose (e.g., administrative, financial) are being used in healthcare. In general, existing regulations address public health risks of software when embedded in a traditional medical device. However, the current application of regulations and controls may not always translate or address the unique public health risks posed by Software as a Medical Device (SaMD) nor assure an appropriate balance between patient/consumer protection and promotion of public health by facilitating innovation. This is the first of a collection of documents that will be developed by the International Medical Device Regulators Forum (IMDRF) to establish a common framework for regulators to incorporate converged controls into their regulatory approaches for SaMD.. This collection of IMDRF SaMD documents will provide regulators with the fundamental building blocks and a common understanding of the many kinds and importance of software for medical purposes in advancing public health. Generally medical purpose software1 consists of: (1) software in a medical device (sometimes referred to as “embedded” or “part of”); (2) software as a medical device (SaMD). This document IMDRF SaMD WG N10/Software as a Medical Device2 : Key Definitions focuses on a common definition for when software is considered to be a medical device and a reminder of other key terms, some previously defined in Global Harmonization Task Force (GHTF) documents, with relevance to SaMD. The key definitions and terms developed in IMDRF SaMD WG N10 will be used to develop future documents that provide a common framework for identifying types of SaMD and associated risks and controls to minimize these risks. Some regulators have taken individual approaches to assure safety, effectiveness, and performance of SaMD. Such approaches have common public health goals. The objective of this effort is to promote consistent expectations for SaMD and to provide an optimal level of patient safety while fostering innovation and ensuring patients and providers have continued access to advances in healthcare technology. 1 Software used to make or maintain a device (testing, source code management, servicing, etc.) is not considered software with a medical purpose. 2 This IMDRF document converges on the term SaMD to replace the term “standalone software” or “standalone medical device software”. However the concepts of standalone software are included in this converged definition of SaMD. 9 December 2013 Page 4 of 9
  • 5. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ 2.0 Scope This document IMDRF SaMD WG N10/Software as a Medical Device: Key Definitions focuses on a common definition for when software is considered to be a medical device and a reminder of other key terms, some previously defined in Global Harmonization Task Force (GHTF) documents, with relevance to SaMD. Software intended as an accessory to a medical device is not in the scope of this document, unless the software meets the definition of SaMD in this document. This document focuses on the definition of the SaMD irrespective of software technology and/or platform (e.g., mobile app, cloud). 3.0 References • GHTF/SG1/N55:2008 Definition of the Terms Manufacturer, Authorised Representative, Distributor and Importer • GHTF/SG1/N70:2011 Label and Instructions for Use for Medical Devices • GHTF/SG1/N71:2012 Definition of Terms Medical Device and In Vitro Diagnostic Medical Device • ISO/IEC 14764:2006 Software Engineering — Software Life Cycle Processes — Maintenance 4.0 Definitions This section is intentionally left blank as the definitions are contained within the body of this document. 9 December 2013 Page 5 of 9
  • 6. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ 5.0 Key Definitions 5.1 Software as a Medical Device The term “Software as a Medical Device” (SaMD) is defined as software intended to be used for one or more medical purposes that perform these purposes without being part of a hardware medical device. NOTES: • SaMD is a medical device and includes in-vitro diagnostic (IVD) medical device. • SaMD is capable of running on general purpose (non-medical purpose) computing platforms3 • “without being part of” means software not necessary for a hardware medical device to achieve its intended medical purpose; • Software does not meet the definition of SaMD if its intended purpose is to drive a hardware medical device. • SaMD may be used in combination (e.g., as a module) with other products including medical devices; • SaMD may be interfaced with other medical devices, including hardware medical devices and other SaMD software, as well as general purpose software • Mobile apps that meet the definition above are considered SaMD. 5.2 Medical purpose The following two terms as defined in GHTF/SG1/N71:2012 (italicized below) identify medical purpose applicable to SaMD: 5.2.1 Medical Device ‘Medical device’ means any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination, for human beings, for one or more of the specific medical purpose(s) of: • diagnosis, prevention, monitoring, treatment or alleviation of disease, • diagnosis, monitoring, treatment, alleviation of or compensation for an injury, • investigation, replacement, modification, or support of the anatomy or of a physiological process, • supporting or sustaining life, • control of conception, 3 “Computing platforms” include hardware and software resources (e.g. operating system, processing hardware, storage, software libraries, displays, input devices, programming languages etc.). “Operating systems” that SaMD require may be run on a server, a workstation, a mobile platform, or other general purpose hardware platform. 9 December 2013 Page 6 of 9
  • 7. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ • disinfection of medical devices, • providing information by means of in vitro examination of specimens derived from the human body; and does not achieve its primary intended action by pharmacological, immunological or metabolic means, in or on the human body, but which may be assisted in its intended function by such means. Note: Products which may be considered to be medical devices in some jurisdictions but not in others include: • disinfection substances, • aids for persons with disabilities, • devices incorporating animal and/or human tissues, • devices for.in-vitro fertilization or assisted reproduction technologies. 5.2.2 In Vitro Diagnostic (IVD) medical device ‘In Vitro Diagnostic (IVD) medical device’ means a medical device, whether used alone or in combination, intended by the manufacturer for the in-vitro examination of specimens derived from the human body solely or principally to provide information for diagnostic, monitoring or compatibility purposes. Note 1: IVD medical devices include reagents, calibrators, control materials, specimen receptacles, software, and related instruments or apparatus or other articles and are used, for example, for the following test purposes: diagnosis, aid to diagnosis, screening, monitoring, predisposition, prognosis, prediction, determination of physiological status. Note2: In some jurisdictions, certain IVD medical devices may be covered by other regulations. 5.2.3 Additional considerations for SaMD SaMD may also: • provide means and suggestions for mitigation of a disease; • provide information for determining compatibility, detecting, diagnosing, monitoring or treating physiological conditions, states of health, illnesses or congenital deformities; • be an aid to diagnosis, screening, monitoring, determination of predisposition; prognosis, prediction, determination of physiological status. 9 December 2013 Page 7 of 9
  • 8. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ 5.3 SaMD Changes SaMD Changes refer to any modifications made throughout the lifecycle of the SaMD including the maintenance phase. Software maintenance4 can include adaptive (e.g. keeps pace with the changing environment), perfective (e.g. recoding to improve software performance), corrective (e.g. corrects discovered problems), or preventive (e.g. corrects latent faults in the software product before they become operational faults). Examples of SaMD changes include, but are not limited to, defect fixes; aesthetic, performance or usability enhancements; and security patches. 5.4 SaMD Manufacturer For SaMD manufacturer the definition in GHTF/SG1/N55:2009 applies: “Manufacturer” means any natural or legal person5 with responsibility for design and/or manufacture of a medical device with the intention of making the medical device available for use, under his name; whether or not such a medical device is designed and/or manufactured by that person himself or on his behalf by another person(s). NOTES: 1. This ‘natural or legal person’ has ultimate legal responsibility for ensuring compliance with all applicable regulatory requirements for the medical device in the countries or jurisdictions where it is intended to be made available or sold, unless this responsibility is specifically imposed on another person by the Regulatory Authority (RA) within that jurisdiction. 2. The manufacturer’s responsibilities are described in other GHTF guidance documents. These responsibilities include meeting both pre-market requirements 4 ISO/IEC 14764:2006 Software Engineering — Software Life Cycle Processes — Maintenance • adaptive maintenance: the modification of a software product, performed after delivery, to keep a software product usable in a changed or changing environment. • perfective maintenance: the modification of a software product after delivery to detect and correct latent faults in the software product before they are manifested as failures • corrective maintenance: the reactive modification of a software product performed after delivery to correct discovered problems • preventive maintenance: the modification of a software product after delivery to detect and correct latent faults in the software product before they become operational faults 5 The term “person” that appears here and in the other definitions of this document, includes legal entities such as a corporation, a partnership or an association. 9 December 2013 Page 8 of 9
  • 9. IMDRF/SaMD WG/N10FINAL:2013 _______________________________________________________________________________________ and post-market requirements, such as adverse event reporting and notification of corrective actions. 3. ‘Design and/or manufacture’, as referred to in the above definition, may include specification development, production, fabrication, assembly, processing, packaging, repackaging, labelling, relabelling, sterilization, installation, or remanufacturing of a medical device; or putting a collection of devices, and possibly other products, together for a medical purpose. 4. Any person who assembles or adapts a medical device that has already been supplied by another person for an individual patient, in accordance with the instructions for use, is not the manufacturer, provided the assembly or adaptation does not change the intended use of the medical device. 5. Any person who changes the intended use of, or modifies, a medical device without acting on behalf of the original manufacturer and who makes it available for use under his own name, should be considered the manufacturer of the modified medical device. 6. An authorised representative, distributor or importer who only adds its own address and contact details to the medical device or the packaging, without covering or changing the existing labelling, is not considered a manufacturer. 7. To the extent that an accessory is subject to the regulatory requirements of a medical device6 , the person responsible for the design and/or manufacture of that accessory is considered to be a manufacturer. 5.5 Intended use / intended purpose For SaMD intended use, the definition in GHTF/SG1/N70:2011 “Label and Instructions for Use for Medical Devices” applies: The term “intended use / intended purpose” is the objective intent of the manufacturer regarding the use of a product, process or service as reflected in the specifications, instructions and information provided by the manufacturer. 5.5.1 Additional considerations for SaMD Although not specifically included in the GHTF definition materials such as sales and marketing materials may be considered as “information provided by the manufacturer” and therefore reflect the objective intent of the manufacturer. Sales and marketing materials should be comprehensive and reflect the intended use of the SaMD. 6 See GHTF/SG1/N29 Information Document Concerning the Definition of the Term “Medical Device” 9 December 2013 Page 9 of 9